Enclosed for your review is a Non-Solicitation, Confidentiality and Assignment Agreement (the Agreement). This offer of employment is conditioned on your willingness to sign and abide by the terms of the Agreement.
In making this offer, the Company understands, and in accepting it you represent that you are not under any obligation to any former employer or any person or entity which would prevent, limit, or impair in any way the performance by you of your duties as an employee of the Company.
The Immigration Reform and Control Act requires employers to verify the employment eligibility and identity of new employees. You will be required to complete a Form 1-9 which will be provided to you before the Start Date. Please bring the appropriate documents listed on that form with you when you report for work. We will not be able to employ you if you fail to comply with this requirement.
This letter agreement and the Agreement referenced above constitute the complete agreement between you and the Company, contain all of the terms of your employment with the Company and supersede any prior agreements, representations or understandings (whether written, oral or implied) between you and the Company. This letter agreement may not be amended or modified, except by an express written agreement signed by both you and a duly authorized officer of the Company, although your job duties, title, reporting relationship, compensation and benefits may change from time to time, at the Companys option.
Please indicate your acceptance of this offer by signing and returning the enclosed copy of this letter no later than Tuesday April 26, 2016.
You may sign, scan, and email the letter to seehrajgverizon.net. We look forward to your joining the Company and are pleased that you will be working with us.
Very truly yours,
/s/ Jasbir S. Seehra
Jasbir S. Seehra, Ph.D.
Chief Executive Officer
Keros Therapeutics, Inc.
Accepted and Agreed:
|/s/ Jennifer L. Lachey 22 Apr 2016|
Jennifer L. Lachey, Ph.D.